EUVIMEDEUVIMED entdecken
Crossref

PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis

Bibo Wu, Shasha Zhao, Jing Zhang, Yao Liu, Jie Bai, Gang Wang, Yu Wang, Han Jiang, Yinxiang Hu, Weiwei OuYang, Bing Lu, Shengfa Su

Inflammation · 2024

DOI: 10.1007/s10753-024-02056-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Bibo Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Pyroptosis, Transforming Growth Factor beta1, Phosphate-Binding Proteins, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Natural Science Foundation, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer therapy has entered a new era with the use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors. When combined with thoracic radiotherapy, it demonstrates synergistic anti-tumor effects and potentially worsens radiation-induced myocardial fibrosis (RIMF). RIMF is the final stage of radiation-induced heart disease (RIHD) and a potentially fatal clinical complication of chest radiotherapy. It is characterized by decreased ventricular elasticity and distensibility, which can result in decreased ejection fraction, heart failure, and even sudden cardiac death. Pyroptosis, a type of programmed cell death, is mediated by members of the gasdermin (GSDM) family and has been associated with numerous cardiac disorders. The effect of pyroptosis on myocardial fibrosis caused by a combination of radiotherapy and PD-1 inhibitors remains uncertain. In this study, a 6MV X-ray of 20 Gy for local heart irradiation was used in the RIHD mouse model. We noticed that PD-1 inhibitors aggravated radiation-induced cardiac dysfunction and RIMF, concurrently enhancing the presence of CD8+ T lymphocytes in the cardiac tissue. Additionally, our findings indicated that the combination of PD-1 inhibitor and thoracic radiation can stimulate caspase-1 to cleave GSDMD, thereby regulating pyroptosis and liberating interleukin-8 (IL-18). In the myocardium of mice, the manifestation of pyroptosis mediated by GSDMD is accompanied by the buildup of proteins associated with fibrosis, such as collagen I, transforming growth factor β1 (TGF-β1), interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), and tumor necrosis factor α (TNF-α). Moreover, it was discovered that TFG-β1 induced the phosphorylation of Smad2/Smad3 when the cardiac underwent PD-1 inhibitor in conjunction with thoracic irradiation (IR). The findings of this research indicate that PD-1 inhibitor worsen RIMF in mice by triggering GSDMD-induced pyroptosis and influencing the TGF-β1/Smads pathway. While using the caspase-1 inhibitor Z-YVAD-FMK, RIMF can be alleviated. Blocking GSDMD may be a viable strategy for managing myocardial fibrosis caused by the combination of PD-1 inhibitors and radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisTransforming Growth Factor beta1Phosphate-Binding ProteinsImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorMyocardiumCardiomyopathiesIntracellular Signaling Peptides and ProteinsPore Forming Cytotoxic ProteinsAnimalsMiceSignal TransductionFibrosisMaleMice, Inbred C57BLGasdermins

Stichwörter der Autor:innen

PD-1 inhibitorTGF-β1pyroptosisradiation-induced myocardial fibrosis

Substanzen

Transforming Growth Factor beta1Phosphate-Binding ProteinsGsdmd protein, mouseImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorIntracellular Signaling Peptides and ProteinsPore Forming Cytotoxic ProteinsPdcd1 protein, mouseTgfb1 protein, mouseGasdermins

Autor:innen und Institutionen

  • Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.
  • Teaching and Research Department of Oncology, Clinical Medical College of Guizhou Medical University, Guiyang, China.
  • Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guiyang, China. sushengfa2005@163.com.
  • Department of Oncology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China. sushengfa2005@163.com.
  • Teaching and Research Department of Oncology, Clinical Medical College of Guizhou Medical University, Guiyang, China. sushengfa2005@163.com.

Förderung

  • National Natural Science Foundation of China
  • Guizhou Provincial Natural Science Foundation, China

Zitieren

APA

Wu, B., Zhao, S., Zhang, J., Liu, Y., Bai, J., Wang, G., Wang, Y., Jiang, H., Hu, Y., OuYang, W., Lu, B., & Su, S. (2024). PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis. Inflammation. https://doi.org/10.1007/s10753-024-02056-9

Vancouver

Wu B, Zhao S, Zhang J, Liu Y, Bai J, Wang G, et al. PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis. Inflammation. 2024. doi:10.1007/s10753-024-02056-9

BibTeX
@article{Wu2024,
  author = {Wu, Bibo and Zhao, Shasha and Zhang, Jing and Liu, Yao and Bai, Jie and Wang, Gang and Wang, Yu and Jiang, Han and Hu, Yinxiang and OuYang, Weiwei and Lu, Bing and Su, Shengfa},
  title = {PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis},
  journal = {Inflammation},
  year = {2024},
  doi = {10.1007/s10753-024-02056-9}
}
Kostenlos starten →